Brain Health Supplements Market to experience growth by 2028

March 09, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Brain Health Supplements Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Brain Health Supplements Market Overview:

The brain health supplements market was estimated at US$ 8.23 billion in 2021 and is expected to grow at a CAGR of 8% during 2022-2028 to reach US$ ~17.40 billion in 2028.

Drivers

The following are the major players in the brain health supplements market:

• AlternaScript
• HVMN Inc.
• Intelligent Labs
• Natural Factors Nutritional Products Ltd.
• NOW Foods
• Onnit Labs, Inc.
• Peak Nootropics
• Purelife Bioscience Co., Ltd.
• Reckitt Benckiser Group plc.
• Teva Pharmaceutical Industries Ltd.

Manufacturers have been concentrating on creating a range of supplements that are specifically aimed at athletes who place an emphasis on improving their performance and preserving their composure. Over the following few years, this is anticipated to increase demand for supplements supporting brain health.

Segment Analysis

The market is segmented based on supplement type, product, age group, application, distribution channel, and geography. On the basis of supplement type, the segment is divided into tablets, capsules, others.

On the basis of product, the segment is divided into natural molecules, herbal extract, vitamins and minerals. In terms of global revenue for 2021, the natural molecule sector held the biggest market share and is predicted to continue to dominate. This market's expansion is anticipated to be aided by the growing preference for brain supplements manufactured from natural ingredients over synthetic ones. Companies are also emphasising the use of natural ingredients in their products.

Based on age group, the market is segmented into children, adults, elderly.

On the basis of application, the market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, stress & anxiety. In terms of global revenue in 2021, the memory improvement sector held the biggest market share and is predicted to continue to dominate. The millennial generation is engaging in a variety of activities outside of their primary occupation, such as adventure sports, social events, and part-time work, which needs them to be intellectually awake throughout the day. Therefore, it is anticipated that changing consumer habits will increase demand for these goods. A survey from the Organization for Economic Cooperation and Development indicates that part-time employment is becoming more prevalent in nations like Germany, Italy, France, and Austria. Over the projection period, the shift in consumer lifestyle is anticipated to increase demand for memory-boosting supplements.

Based on distribution channel, the market is divided into supermarkets & hypermarkets, drug stores, online stores, and others.

The brain health supplements market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2021, North America contributed most to the market. The demand for the product in North America is being driven by consumers' increased concerns about their mental health. Nearly 75% of U.S. adults consume dietary supplements that contain vitamins, minerals, and herbal ingredients to enhance brain health, energy, and performance, according to statistics released by the U.S. National Library of Medicine in April 2020. These trends are probably going to accelerate the market expansion in the nation. In America, loneliness and uncertainty about the future are major stressors for adolescents and young adults, according to data published by the American Psychological Association in October 2020, which is expected to lead an increase in the number of adults to use brain health supplements for the right kind of treatment.

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/3114/brain-health-supplements-market.html#form

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]

 

Cancer Supportive Care Drugs Market: Revenue and growth prediction till 2026 with covid-19 impact analysis

March 07, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Cancer Supportive Care Drugs Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Cancer Supportive Care Drugs Market Overview:

The cancer supportive care drugs market was estimated at US$ 20.9 billion in 2021 and is expected to grow at a CAGR of 2.04% during 2022-2028 to reach US$ ~21.40 billion in 2028.

Drivers

The following are the major players in the cancer supportive care drugs market:

• Amgen, Inc.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc (GSK)
• Helsinn Healthcare SA
• Heron Therapeutics, Inc.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG

Rising technological and therapeutic developments as well as an increase in product launches by market participants are factors driving the growth of the global market for asthma and COPD medications. For the introduction of new products, certain governmental organisations work with industry participants.

Segment Analysis

Based on drug class, application, distribution channel, and geography, the market has been divided into segments. On the basis of drug class, the market has been segmented into G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), anti-emetics, bisphosphonates, opioids, NSAIDs, and others. The Granulocyte Colony Stimulating Factor (G-CSF) category had the highest revenue. It is the main option for treating neutropenia brought on by cancer. It is one of the most frequently prescribed supportive care medications for lymphoma and breast malignancies. For instance, in the UK, G-CSF is given to 84% of patients with lymphoma and 70% of breast cancer patients, respectively. However, the declining usage of myelosuppressive chemotherapy, which limits the formation of G-CSF, is a consequence of the increased use of immuno-oncology (IO) drugs in therapy, such as anti-PD-1/L1s. During the anticipated term, positive growth in the antiemetics segment is anticipated.

Chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent issues that patients with chemotherapy deal with. The introduction of more recent medications including Cinvanti, Sustol, and Varubi is to blame for the rise. However, the overall CINV medicines sales would be impacted by the patent expiry of important antiemetic medications like Emend. During the projection period, the growth of the opioid segment is anticipated to slow. Opioid medicines are subject to strict controls imposed by governments in many nations, including the US government. As a result, the rate of opioid medicine prescriptions has dramatically decreased.

Based on application, the cancer supportive care drugs market has been divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, stomach cancer, and others.

On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies.

The cancer supportive care drugs market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The launch and quick adoption of biosimilars as well as curbs on the prescription of opioids are likely to cause the market in North America and other developed regions to contract over the course of the forecast period. Additionally, tailored, targeted medicines are widely used in these regions due to their lower incidence of adverse effects, increasing public knowledge of their availability, and supportive reimbursement practises for expensive targeted therapies. High unmet needs for cancer supportive care exist in developing nations such those in the Middle East and Africa, Latin America, and Asia-Pacific. Chemotherapy is still a common treatment because of the underdeveloped healthcare systems and low levels of disposable income in these areas. These elements are anticipated to fuel market expansion in these regions.

Get access to a deeper coverage of the impact of COVID-19 on this Market here:https://www.stratviewresearch.com/Request-Sample/3140/cancer-supportive-care-drugs-market.html#form

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]

 

Covid-19 Impact on Immunology Drug Market to Witness Growth Acceleration During 2021-2026

The report on the Immunology Drug Market is segmented By Drug Type (Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication), By Application (Hospitals, Clinics, Cancer Research Centers and Institutes), and Region The historic years considered for the study are 2016-2019, base year is 2020, estimated year is 2021, and forecast period is 2021-2026.

Market Insights

The Immunology Drug market is projected to grow from USD 85.7 billion in 2020 to USD 135.8 billion by 2026 at a CAGR of around 8.2% during the forecast period.

Key players

Some of the major players operating in the global Immunology Drug Market are-

• Pfizer Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• AbbVie, Inc. (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• Merck Sharp & Dohme Corp. (U.S.)
• Novartis AG (Switzerland)
• Janssen Global Services, LLC (U.S.)
• Amgen Inc. (U.S.)
• Astellas Pharma Inc. (Japan)
• UCB SA (Belgium)

Report Features

The report provides critical insights into the market dynamics that enables strategic decision making that is critical to the growth of the existing players as well as those planning to enter the market. This report offers an improvised approach to consolidate the growth decisions by covering the following features –

• Market structure - as it reflects the value chain of different commodities in the market.
• Drivers and Constraints - as both can affect any element of the marketing mix -- product, budget, and place, etc.
• Market Forecast - a part of the decision-making process. This helps users with facts regarding projected sales dimensions, costs, market shares, and other areas of planning.
• Competitive landscape and dynamics: The user can determine the strengths and gaps. The information mentioned here will work towards enhancing the brand's strategy.
• Growth strategies - allowing a small business to survive unexpected changes, and to grow into a bigger entity, and gain a greater competitive advantage.

Market Dynamics

The report covers maximum factors that affect the Immunology Drug Market. According to this report,

The rise in the prevalence rate of various types of cancer and rheumatoid cancer, growing funding from the various government & non-government organizations, and increasing government initiatives, are some of the key factors augmenting the immunology drug market growth. Moreover, patients with poor prognoses are further expected to boost the growth of the immunology drug trial evidence reveals which after preparing the immune system to fight against cancer immunology, drug effects last for a long time even after the reduction of the tumor. However, the high cost of these drugs is likely to hamper industry growth.

Segments' Analysis

Drug Type Trends

By drug type, the immunology drug market has been classified into monoclonal antibodies (mAb), antibody-drug conjugates, interferon and cytokine therapies, immunosuppressive medication. Under these, the monoclonal antibodies (mAb) segment accounted for a significant market share in 2020 and is projected to register significant growth during the review period. This is mainly attributed to the rising number of approvals for mAb by the government bodies to treat chronic ailments across the globe, further fostering segment growth.

Regional Trends

By region, the market in North America accounted for a significant market share in 2020 and is projected to grow at a significant CAGR during the assessment period. This is mainly ascribed to the rising prevalence of chronic ailments, robust healthcare infrastructure, the higher diagnosis rate of the patients, increasing healthcare expenditure, and a large number of home healthcare facilities, which further proliferates the regional market growth.

Critical Questions Answered in the Report

• What are the key trends in the global Immunology Drug Market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
• What is the impact of COVID-19 on global Immunology Drug Market?
• What are the key strategies adopted by the major vendors to lead in the global Immunology Drug Market?
• What is the market share of the top vendors?

Wish to know more about the study? Click here to get a free sample. https://www.stratviewresearch.com/Request-Sample/2327/Immunology-Drug-Market.html#form

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [phone].

About Us –

Stratview Research is a leading global Market Research firm providing expert research solutions, trusted by clients worldwide. This firm possesses a global presence to enable current market information using the most up-to-date methodology, best-in-class research techniques, and cost-effective approaches. It also surveys clients in several countries to provide you with the most comprehensive illustration of global trends and behaviours.

Contact -
Web: https://www.stratviewresearch.com/contact

Email: [e-mail]